Tigenix The Latest To Find Stem Cell Appetite In Japan – Seeking Alpha
|
Tigenix The Latest To Find Stem Cell Appetite In Japan
Seeking Alpha Tigenix (OTC:TGXSF) is lucky that Japanese companies are still willing to bet against the odds on stem cell therapies. Otherwise it would have struggled to license out Cx601 – Takeda (OTCPK:TKPYY) emerged as its ex-US partner today – and gloss over the … TiGenix licenses ex-US rights for Cx601 stem cell treatment to TakedaPharmaceutical Business Review Takeda snatches up Belgian Cell therapy for Crohn’s DiseaseLabiotech.eu (blog) |
Genetic Literacy Project |
Stem cell clinics selling risky treatments explode across the country
Pharmacy Today, American Pharmacists Association, pharmacist.com The availability of experimental stem cell treatments has been widely underestimated in the United States, according to researchers, who warn that unapproved procedures pose a threat to patients’ pocketbooks and their health. They also worry that … Rise in unproven US stem cell clinics worry experts |
Irish Examiner |
Dolly The Sheep may have pushed stem cell research forward 20 years
Irish Examiner Stem cell research might be 20 years behind where it is today if Dolly the Sheep had never been born, according to the scientist whose team created the world’s first mammal cloned from an adult cell. Speaking on the eve of Dolly’s 20th anniversary … Dolly triggered stem cell researchYahoo7 News 20 Years after Dolly the Sheep Led the Way—Where Is Cloning Now?Scientific American Dolly the Sheep creator Sir Ian Wilmut says ‘Noah’s Ark’ of cloned stem cells could halt extinctionsThe National Scotland Now –STAT all 58 news articles » |